fashion -WSS

fashion

author：explore 2025-10-02 01:08:19 - browse：5662

To scientists' surprise in a new study, a common genetic deletion in schizophrenia cases was linked to problems in mitochondria. Adobe

The heritable nature of schizophrenia has been known for about a century. But researchers are still trying to learn how genes that have been linked to an increased risk of the disease actually lead to schizophrenia.

For decades, those genetic underpinnings of schizophrenia have fascinated Jennifer Mulle, an associate professor at the Rutgers Center for Advanced Biotechnology and Medicine. When she was a master’s student in public health, she set out to locate a place in the DNA that held the secrets of the condition. “We did really beautifully, carefully designed studies,” she said. “And there was nothing.”

In the early 2000s, before they knew many genes factor into schizophrenia, researchers were looking for a single gene that would be culpable for the devastating illness. Mulle spent nearly a decade on the hunt, through her Ph.D. program and into her postdoctoral fellowship at Emory University. Under the mentorship of Stephen Warren, who founded the medical school’s department of human genetics and unearthed the genetics of fragile X syndrome, she finally found something.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： WHO may add ‘noma' to its list of neglected tropical diseases

WSS

Mom launches Girl Scout troop for LGBTQ youth in Texas

How to fix the rural physician shortage in the U.S.

Biden's order seeks to regulate AI risk without stifling innovation

First Opinion Podcast: How to protect health care in times of war

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

A public health expert passes on football's full body collisions for youths

entertainment

fashion

focus

Drug repurposing or repositioning? The language matters

How to fix the rural physician shortage in the U.S.

Dobbs anniversary: the lost opportunity of abortion as health care

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

BioMarin wins approval for gene therapy to treat hemophilia A

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly’s Mounjaro succeeds in second weight

Hepatitis C has a cure — but many Americans still lack access to it

Xenotransplantation trials will require adjusting expectations, experts say

focus

Emergency medicine has repudiated 'excited delirium.' Now what?

Eli Lilly to pay $200M for Beam’s stake in gene

Physician subsidies by hospitals soar in wake of No Surprises Act

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Biden's order seeks to regulate AI risk without stifling innovation

Patients, doctors are clashing about side effects of hormonal birth control

hotspot

entertainment

focus

Wikipedia